ArticleInternational journal of molecular sciences2026
Med9 Is a Novel eIF4E-Interacting Protein in
Dora E Vélez, Zorica Ristic, Daniela Ross-Kaschitza, Michael Altmann, Angélica Montiel-Dávalos, Vincent G Osnaya, Yolanda Camacho-Villasana, Xochitl Pérez-Martínez, Greco Hernández
Abstract read
In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Dora E VélezmRNA and Cancer Laboratory, Subdirección de Investigación Básica, National Institute of Cancer (Instituto Nacional de Cancerología, INCan), Mexico City 14080, Mexico.
Zorica RisticInstitut für Biochemie und Molekulare Medizin (IBMM), Universität Bern, 3012 Bern, Switzerland.
Daniela Ross-KaschitzaInstitut für Biochemie und Molekulare Medizin (IBMM), Universität Bern, 3012 Bern, Switzerland.
Michael AltmannInstitut für Biochemie und Molekulare Medizin (IBMM), Universität Bern, 3012 Bern, Switzerland.
Angélica Montiel-DávalosmRNA and Cancer Laboratory, Subdirección de Investigación Básica, National Institute of Cancer (Instituto Nacional de Cancerología, INCan), Mexico City 14080, Mexico.
Vincent G OsnayamRNA and Cancer Laboratory, Subdirección de Investigación Básica, National Institute of Cancer (Instituto Nacional de Cancerología, INCan), Mexico City 14080, Mexico.
Yolanda Camacho-VillasanaCell Physiology Institute (Instituto de Fisiología Celular), Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Xochitl Pérez-MartínezCell Physiology Institute (Instituto de Fisiología Celular), Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0002-3651-8413 Greco HernándezmRNA and Cancer Laboratory, Subdirección de Investigación Básica, National Institute of Cancer (Instituto Nacional de Cancerología, INCan), Mexico City 14080, Mexico.ORCID 0000-0002-5318-4443 Funding
Instituto Nacional de Cancerología IN220026; 31003A_146722/1;
6 · The paper itselfAbstract
The cap-binding protein eukaryotic initiation factor (eIF) 4E is a key protein for mRNA metabolism. The biological role of eIF4E is defined by the specific protein it interacts with. Thus, eIF4E binds to a constellation of partners across eukaryotes. The best-characterized role of eIF4E is to promote mRNA translation through interaction with the translation factor eIF4G. To seek new interactors in the ascomycete
Indexed as
Eukaryotic Initiation Factor-4EMediator ComplexSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsEukaryotic Initiation Factor-4GProtein BindingTwo-Hybrid System TechniquesEukaryotic Initiation Factor-4EEukaryotic Initiation Factor-4GMediator ComplexSaccharomyces cerevisiae ProteinsTIF4631 protein, S cerevisiaecarbon sourceeIF4EMed9mRNA metabolismtranslation initiation
Identifiers
PMID42589564
PMCPMC13467561
What OpenQuestion holds
Textmetadata
Read underepoch 390